Activated CD4+ and CD8+ T Cell Proportions in Multiple Sclerosis Patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Link
http://link.springer.com/content/pdf/10.1007/s10753-016-0441-0.pdf
Reference17 articles.
1. Harrer, A., G. Pilz, P. Wipfler, K. Oppermann, J. Sellner, W. Hitzel, E. Haschke-Becher, S. Afazel, T. Rispens, D. van der Kleij, E. Trinka, and J. Kraus. 2015. High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis. Clinical Experimental Immunology 180: 383–392.
2. Rudnicka, J., M. Czerwiec, E. Grywalska, D. Siwicka-Gieroba, M. Walankiewicz, A. Grafka, M. Zgurski, A. Surdacka, H. Bartosik-Psujek, and J. Rolinski. 2015. Influence of fingolimod on basic lymphocyte subsets frequencies in the peripheral blood of multiple sclerosis patients—preliminary study. Central European Journal of Immunology 40: 354–359.
3. Stüve, O., C.M. Marra, A. Bar-Or, M. Niino, P.D. Cravens, S. Cepok, E.M. Frohman, J.T. Phillips, G. Arendt, K.R. Jerome, L. Cook, F. Grand’Maison, B. Hemmer, N.L. Monson, and M.K. Racke. 2006. Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis. Archives of Neurology 63: 1383–1387.
4. Arneth, B. 2015. Early activation of CD4+ and CD8+ T lymphocytes by myelin basic protein in subjects with MS. Journal of Translational Medicine 13: 341.
5. Hernández-Hoyos, G., M. Anderson, C. Wang, E. Rothenberg, and J. Alberola-Ila. 2003. GATA-3 expression is controlled by TCR signals and regulates CD4/CD8 differentiation. Immunity 19: 83–94.
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current Knowledge about CD3+CD20+ T Cells in Patients with Multiple Sclerosis;International Journal of Molecular Sciences;2024-08-18
2. Primary Progressive Multiple Sclerosis—A Key to Understanding and Managing Disease Progression;International Journal of Molecular Sciences;2024-08-11
3. Dissecting the causal role of immunophenotypes in primary sclerosing cholangitis risk: A Mendelian randomization study;Medicine;2024-06-28
4. Cell-Mediated Immunity in Multiple Sclerosis Patients Who Discontinued Therapy with an Integrin Inhibitor;Annals of Clinical and Experimental Neurology;2024-04-05
5. Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence;Journal of Clinical Medicine;2023-02-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3